UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 619

Sortiert nach

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

Cancer science, 2015-11, Vol.106 (11), p.1561-1567

2015

Link zum Volltext

Verfügbarkeit prüfen

The Collaborative Payer Provider Model Enhances Primary Care, Producing Triple Aim Plus One Outcomes: A Cohort Study

Healthcare (Basel), 2017-08, Vol.5 (3), p.48

2017

Link zum Volltext

Verfügbarkeit prüfen

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.781-794

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Blood, 2022-11, Vol.140 (Supplement 1), p.9491-9492

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of an evidence-based computerized decision support system on primary care prescription costs

Annals of family medicine, 2004-09, Vol.2 (5), p.494-498

2004

Link zum Volltext

Verfügbarkeit prüfen

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.5058-5059

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

Blood, 2020-11, Vol.136 (Supplement 1), p.2-3

2020

Link zum Volltext

Verfügbarkeit prüfen

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8504-8504

2020

Link zum Volltext

Verfügbarkeit prüfen

MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS8610-TPS8610

2015

Link zum Volltext

Verfügbarkeit prüfen

ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S379

2022

Link zum Volltext

Verfügbarkeit prüfen

Poster: ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S164

2022

Link zum Volltext

Verfügbarkeit prüfen

MM-004: A Phase 1, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination with Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma in Japan

Blood, 2014-12, Vol.124 (21), p.2107-2107

2014

Link zum Volltext

Verfügbarkeit prüfen

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

Blood, 2014-12, Vol.124 (21), p.4730-4730

2014

Link zum Volltext

Verfügbarkeit prüfen

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

Blood, 2015-12, Vol.126 (23), p.5374-5374

2015

Link zum Volltext

Verfügbarkeit prüfen

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability Of Pomalidomide + Low-Dose Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment

Blood, 2013-11, Vol.122 (21), p.5393-5393

2013

Link zum Volltext

Verfügbarkeit prüfen

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions

Aerospace science and technology, 2002-11, Vol.6 (7), p.495-506

2002

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the AV Delay in DDD Pacemaker Patients with High Degree AV Block: Mitral Valve Doppler Versus Impedance Cardiography

Pacing and clinical electrophysiology, 1997-10, Vol.20 (10), p.2453-2462

1997

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial

Experimental hematology & oncology, 2016-04, Vol.5 (11), p.11-11, Article 11

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of atrial rhythm disturbances is a function of AV-delay, not of lower rate limit

Heart rhythm, 2005-05, Vol.2 (5), p.S322-S323

2005

Link zum Volltext

Verfügbarkeit prüfen

Platinum, Palladium and Rhodium in a Bavarian Roadside Soil

Platinum Metals in the Environment, 2015, p.145-151

2015

Link zum Volltext

Verfügbarkeit prüfen

Neue Strukturen für das Hochschulsystem in China: Akademikerarbeitslosigkeit versus Fachkräftemangel

Forschung & Lehre (Bonn), 2015, Vol.22 (10), p.838-840

Schmidt-Dörr, Thomas

2015

Link zum Volltext

Verfügbarkeit prüfen

Studieren in China: Gaokao oder Auslandsstudium?

Forschung & Lehre (Bonn), 2014, Vol.21 (11), p.906-907

Schmidt-Dörr, Thomas

2014

Link zum Volltext

Verfügbarkeit prüfen

Discussing cancer screening with elderly patients

JAMA : the journal of the American Medical Association, 2001-09, Vol.286 (10), p.1175

Cunningham, J

2001

Link zum Volltext

Verfügbarkeit prüfen

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions: Combustion

Aerospace science and technology, 2002, Vol.6 (7), p.495-506

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 619

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(556)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

The Collaborative Payer Provider Model Enhances Primary Care, Producing Triple Aim Plus One Outcomes: A Cohort Study

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

Impact of an evidence-based computerized decision support system on primary care prescription costs

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)

MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM)

ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Poster: ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study

Pomalidomide (POM), bortezomib, and low‐dose dexamethasone (PVd) vs bortezomib and low-dose dexamethasone (Vd) in lenalidomide (LEN)-exposed patients (pts) with relapsed or refractory multiple myeloma (RRMM): Phase 3 OPTIMISMM trial

MM-004: A Phase 1, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination with Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma in Japan

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability of Pomalidomide + Low-Dose Dexamethasone in Patients with Relapsed or Refractory and Refractory Multiple Myeloma and Renal Impairment

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

MM-008: A Phase 1 Trial Evaluating Pharmacokinetics and Tolerability Of Pomalidomide + Low-Dose Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions

Optimizing the AV Delay in DDD Pacemaker Patients with High Degree AV Block: Mitral Valve Doppler Versus Impedance Cardiography

A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial

Incidence of atrial rhythm disturbances is a function of AV-delay, not of lower rate limit

Platinum, Palladium and Rhodium in a Bavarian Roadside Soil

Neue Strukturen für das Hochschulsystem in China: Akademikerarbeitslosigkeit versus Fachkräftemangel

Studieren in China: Gaokao oder Auslandsstudium?

Discussing cancer screening with elderly patients

Modelling of the atomization of a plain liquid fuel jet in crossflow at gas turbine conditions: Combustion

Suchergebnisse filtern